GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » EV-to-EBIT

Synthetic MR AB (XSAT:SYNT) EV-to-EBIT : 90.76 (As of May. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Synthetic MR AB's Enterprise Value is kr1,191.98 Mil. Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr13.13 Mil. Therefore, Synthetic MR AB's EV-to-EBIT for today is 90.76.

The historical rank and industry rank for Synthetic MR AB's EV-to-EBIT or its related term are showing as below:

XSAT:SYNT' s EV-to-EBIT Range Over the Past 10 Years
Min: -414.37   Med: 102.02   Max: 2091.26
Current: 90.76

During the past 12 years, the highest EV-to-EBIT of Synthetic MR AB was 2091.26. The lowest was -414.37. And the median was 102.02.

XSAT:SYNT's EV-to-EBIT is ranked worse than
95.09% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs XSAT:SYNT: 90.76

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Synthetic MR AB's Enterprise Value for the quarter that ended in Dec. 2023 was kr1,087.86 Mil. Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr13.13 Mil. Synthetic MR AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.21%.


Synthetic MR AB EV-to-EBIT Historical Data

The historical data trend for Synthetic MR AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB EV-to-EBIT Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 176.36 1,578.67 238.77 172.99 82.83

Synthetic MR AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.99 140.03 129.30 120.18 82.83

Competitive Comparison of Synthetic MR AB's EV-to-EBIT

For the Health Information Services subindustry, Synthetic MR AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's EV-to-EBIT falls into.



Synthetic MR AB EV-to-EBIT Calculation

Synthetic MR AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1191.982/13.133
=90.76

Synthetic MR AB's current Enterprise Value is kr1,191.98 Mil.
Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB  (XSAT:SYNT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Synthetic MR AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=13.133/1087.85528
=1.21 %

Synthetic MR AB's Enterprise Value for the quarter that ended in Dec. 2023 was kr1,087.86 Mil.
Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 105,384 Shares

By GuruFocus Research GuruFocus Editor 12-16-2010

Syntel: A contrarian's delight

By nicklaskastrup Dhandoisms 05-15-2015

Syntel Inc. (SYNT) CFO & CISO Arvind Godbole sells 2,175 Shares

By GuruFocus Research GuruFocus Editor 12-09-2010

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 2,610,000 Shares

By GuruFocus Research GuruFocus Editor 11-22-2010

RM LAW Announces Investigation of Syntel, Inc.

By PRNewswire PRNewswire 07-26-2018

Gurus Find Hot Information Technology Stocks

By James Li James Li 06-10-2016

Syntel Named a Partner of the Year by Pivotal

By Marketwired Marketwired 09-25-2018